Changes in sleep and wakefulness following 5-HT1A ligands given systemically and locally in different brain regions

scientific article

Changes in sleep and wakefulness following 5-HT1A ligands given systemically and locally in different brain regions is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1515/REVNEURO.1998.9.4.265
P698PubMed publication ID9886141

P50authorBjørn BjorvatnQ17057497
Reidun UrsinQ76450575
P2860cites workDose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat.Q33884340
The 5-HT1A antagonist (-)-alprenolol fails to modify sleep or zimeldine-induced sleep-waking effects in ratsQ34540032
Cholinergic nucleus basalis neurons display the capacity for rhythmic bursting activity mediated by low-threshold calcium spikesQ35661947
5-HT1 receptors and behaviorQ35942139
Serotonin hyperpolarizes cholinergic low-threshold burst neurons in the rat laterodorsal tegmental nucleus in vitroQ36797732
Effect of antipsychotic drugs on the firing of dorsal raphe cells. I. Role of adrenergic systemQ39117180
Biogenic amines and the states of sleepQ39890680
Raphe unit activity in freely moving cats: Correlation with level of behavioral arousalQ40215755
Current advances and trends in the treatment of depressionQ41028584
5-HT receptor classification and nomenclature: towards a harmonization with the human genomeQ41533296
Short-term effects of fluoxetine and trifluoromethylphenylpiperazine on electroencephalographic sleep in the rat.Q42216690
Unit activity of rat basal forebrain neurons: relationship to cortical activityQ42438615
Pharmacological and immunohistochemical evidence for serotonergic modulation of cholinergic nucleus basalis neurons.Q42503518
Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortexQ42520623
Ipsapirone, a 5-HT1A agonist, suppresses REM sleep equally in unmedicated depressed patients and normal controlsQ44513254
Behavioral, sleep-waking and EEG power spectral effects following the two specific 5-HT uptake inhibitors zimeldine and alaproclate in catsQ44741141
Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimeldine on EEG sleep and waking stages in the rat.Q45235021
5-HT1-like receptor agonists enhance wakefulnessQ46118679
The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjectsQ46360645
Human sleep EEG following the 5-HT1A antagonist pindolol: possible disinhibition of raphe neuron activityQ46444110
Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep: an in vitro electrophysiological studyQ46902344
Serotonergic synaptic input to cholinergic neurons in the rat mesopontine tegmentumQ48106896
Depletion of brain serotonin by 5,7-DHT: effects on the 8-OH-DPAT-induced changes of sleep and waking in the rat.Q48119235
The effects of 5-hydroxytryptophan andl-tryptophan on wakefulness and sleep patterns in the catQ48392588
Dorsal raphe neurons: depression of firing during sleep in catsQ48406686
On-line detection of extracellular levels of serotonin in dorsal raphe nucleus and frontal cortex over the sleep/wake cycle in the freely moving rat.Q48522681
Fluoxetine decreases brain temperature and REM sleep in Syrian hamstersQ48548849
Sleep/waking effects of a selective 5-HT1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in ratsQ48559536
l-Tryptophan: Effects on daytime sleep latency and the waking EEGQ48560097
Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteersQ48713746
The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptorsQ48716431
Diurnal differences in L-tryptophan sleep and temperature effects in the rat.Q48829027
Central administration of two 5-HT receptor agonists: effect on REM sleep initiation and PGO wavesQ48834569
Effects of the selective 5-HT1B agonist, CGS 12066B, on sleep/waking stages and EEG power spectrum in ratsQ48840755
Stereoselective antagonism by the pindolol enantiomers of 8-OH-DPAT-induced changes of sleep and wakefulnessQ48846306
Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in ratsQ48857389
The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat.Q48858788
Effects of ipsapirone, a 5-HT1A agonist, on sleep/wakefulness cycles: probable post-synaptic actionQ48867459
Functional activity of 5-HT2 receptors in the modulation of the sleep/wakefulness statesQ48883898
The effect of 3-h and 6-h sleep deprivation on sleep and EEG spectra of the rat.Q48930654
Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to ratsQ48939885
Suppressant effects of selective 5-HT2 antagonists on rapid eye movement sleep in ratsQ48943475
Increased sleep following intracerebroventricular injection of the delta sleep-inducing peptide in ratsQ49104588
Sleep and EEG power spectrum effects of the 5-HT1A antagonist NAN-190 alone and in combination with citalopramQ49132874
The effect of para-chlorophenylalanine on the sleep of catsQ49135347
5-HT antagonists suppress sleep and delay its restoration after 5-HTP in p-chlorophenylalanine-pretreated catsQ49135702
Differential effect of para-chlorophenylalanine on the two slow wave sleep stages in the cat.Q54625119
P433issue4
P304page(s)265-273
P577publication date1998-01-01
P1433published inReviews in the NeurosciencesQ15750651
P1476titleChanges in sleep and wakefulness following 5-HT1A ligands given systemically and locally in different brain regions
P478volume9